Adding Metastasis-Directed Radiation Therapy Boosts Progression-Free Survival in Metastatic Pancreatic Cancer
August 06, 2024
August 06, 2024
HOUSTON, Texas, Aug. 6 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Approach achieves some of the longest progression-free survival times reported in a clinical trial for metastatic pancreatic cancer
* * *
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved . . .
* * *
Approach achieves some of the longest progression-free survival times reported in a clinical trial for metastatic pancreatic cancer
* * *
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved . . .